Compared to serum PSA, measurement of [CITRATE] is disadvantageous relative to the practical aspects of sample collection and cannot be used in the follow-up of patients with PCa subjected to radical prostatectomy or of men with BPH subjected to surgery who subsequently develop retrograde ejaculation. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.